title: Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer.
authors.forename: A
authors.initials: A
authors.lastname: Alimonti
authors.forename: F
authors.initials: F
authors.lastname: Satta
authors.forename: I
authors.initials: I
authors.lastname: Pavese
authors.forename: E
authors.initials: E
authors.lastname: Burattini
authors.forename: V
authors.initials: V
authors.lastname: Zoffoli
authors.forename: A
authors.initials: A
authors.lastname: Vecchione
mesh_terms: D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects*; D001414:Bacitracin / Q000008:administration & dosage* / Q000009:adverse effects; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced / Q000517:prevention & control*; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects*; D009355:Neomycin / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D001414:Bacitracin; D000077146:Irinotecan; D009355:Neomycin; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin